EUVIMEDEUVIMED entdecken
Crossref

Serum soluble PD-L1 predicts hepatocellular carcinoma development across distinct virological cohorts of chronic hepatitis C

Kazumi Yamasaki, Masashi Mizokami, Megumi Goto, Shinya Nagaoka, Akira Saeki, Yasuhide Motoyoshi, Tomoyuki Suehiro, Yuki Kugiyama, Atsumasa Komori, Jun Ohashi, Hiroshi Yatsuhashi

Hepatology International · 2026-06 · 20 (3) · 619-631

DOI: 10.1007/s12072-026-11075-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatology International, online erschienen am 07.04.2026. Verfasst von Kazumi Yamasaki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, NHO Nagasaki Medical Center, 2-1001-1, Kubara, Omura, Nagasaki, 856-8562, Japan. rsr03768@nifty.com. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis C, Chronic, Liver Neoplasms, B7-H1 Antigen. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularHepatitis C, ChronicLiver NeoplasmsB7-H1 AntigenHumansFemaleMaleMiddle AgedCohort StudiesAntiviral AgentsSustained Virologic ResponseAgedBiomarkers, TumorAdult

Stichwörter der Autor:innen

BiomarkerChronic hepatitis CDAAFIB-4 indexHepatocellular carcinomaLiver fibrosisM2BPGiRisk stratificationSoluble PD-L1aMAP score

Substanzen

B7-H1 AntigenCD274 protein, humanAntiviral AgentsBiomarkers, Tumor

Autor:innen und Institutionen

  • Clinical Research Center, NHO Nagasaki Medical Center, 2-1001-1, Kubara, Omura, Nagasaki, 856-8562, Japan. rsr03768@nifty.com.
  • Molecular and Cellular Glycoproteomics Research Group, Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba, 305-8565, Japan.
  • Department of Genome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Ichikawa, Chiba, Japan.
  • Sysmex Corporation, Kobe, Hyogo, Japan.
  • Clinical Research Center, NHO Nagasaki Medical Center, 2-1001-1, Kubara, Omura, Nagasaki, 856-8562, Japan.
  • Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.

Zitieren

APA

Yamasaki, K., Mizokami, M., Goto, M., Nagaoka, S., Saeki, A., Motoyoshi, Y., Suehiro, T., Kugiyama, Y., Komori, A., Ohashi, J., & Yatsuhashi, H. (2026). Serum soluble PD-L1 predicts hepatocellular carcinoma development across distinct virological cohorts of chronic hepatitis C. Hepatology International, 20(3), 619-631. https://doi.org/10.1007/s12072-026-11075-7

Vancouver

Yamasaki K, Mizokami M, Goto M, Nagaoka S, Saeki A, Motoyoshi Y, et al. Serum soluble PD-L1 predicts hepatocellular carcinoma development across distinct virological cohorts of chronic hepatitis C. Hepatology International. 2026;20(3):619-631. doi:10.1007/s12072-026-11075-7

BibTeX
@article{Yamasaki2026,
  author = {Yamasaki, Kazumi and Mizokami, Masashi and Goto, Megumi and Nagaoka, Shinya and Saeki, Akira and Motoyoshi, Yasuhide and Suehiro, Tomoyuki and Kugiyama, Yuki and Komori, Atsumasa and Ohashi, Jun and Yatsuhashi, Hiroshi},
  title = {Serum soluble PD-L1 predicts hepatocellular carcinoma development across distinct virological cohorts of chronic hepatitis C},
  journal = {Hepatology International},
  year = {2026},
  volume = {20},
  number = {3},
  pages = {619--631},
  doi = {10.1007/s12072-026-11075-7}
}
Kostenlos starten →